Topic

Trikafta (elexacaftor/tezacaftor/ivacaftor)

A collection of 29 issues

Getting Trikafta Approved by Aetna CVS Health in California: Complete Prior Authorization and Appeals Guide 2024

Answer Box: Getting Trikafta Covered by Aetna CVS Health in California Trikafta requires prior authorization from Aetna CVS Health. Submit documentation including CFTR genotype test results, cystic fibrosis diagnosis (ICD-10: E84.0-E84.9), and clinical notes. If denied, file an internal appeal within 180 days, then request California's

Getting Trikafta Covered by Humana in Pennsylvania: Prior Authorization, Appeals, and Coding Guide

Answer Box: Fast Track to Trikafta Coverage Trikafta requires prior authorization from Humana Medicare in Pennsylvania. Submit CFTR genotype documentation (F508del or other responsive mutations), current liver function tests, and ICD-10 code E84.0-E84.9 for cystic fibrosis. Humana decides within 7 days for standard requests, 72 hours for expedited.

How to Get Trikafta Covered by UnitedHealthcare in New York: Prior Authorization, Appeals & Specialty Pharmacy Guide

Answer Box: Getting Trikafta Covered by UnitedHealthcare in New York Trikafta requires prior authorization from UnitedHealthcare and must be filled through an approved specialty pharmacy like Optum Specialty Pharmacy. The drug is placed on Tier 3 (specialty tier) with the highest cost-sharing. To get approved: (1) Your doctor submits a

How to Get Trikafta Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Trikafta Covered in Washington Trikafta requires prior authorization from Blue Cross Blue Shield plans in Washington (Premera, Regence). The fastest path: (1) Confirm your CFTR genotype documentation with F508del mutation, (2) Have your CF specialist submit PA with baseline labs and pulmonary function tests, (3) Ensure prescription

Work With Your Doctor to Get Trikafta Covered by Blue Cross Blue Shield in North Carolina: Complete Provider Collaboration Guide

Answer Box: Getting Trikafta Approved in North Carolina Your fastest path to Trikafta approval: Work directly with your CF specialist to submit a complete prior authorization with CFTR genetic testing results, baseline liver function tests, and a detailed medical necessity letter. Blue Cross Blue Shield of North Carolina requires these

Getting Trikafta Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Fast Track to Trikafta Coverage To get Trikafta covered by Cigna in Washington: 1) Confirm your CFTR genetic testing shows an FDA-approved mutation, 2) Have your CF specialist submit a prior authorization with baseline labs and medical necessity letter, 3) If denied, file an internal appeal within 180

How to Get Trikafta Covered by Florida Blue Cross Blue Shield: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Trikafta Covered by Florida Blue Florida Blue requires prior authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor) with documented CFTR genotype testing. To get approval: (1) Confirm your genetic mutation is FDA-approved for Trikafta, (2) Have your CF specialist submit a prior authorization form with baseline labs and clinical

How to Get Trikafta Covered by Aetna CVS Health in Ohio: Prior Authorization Forms, Appeal Process & Alternatives

Answer Box: Getting Trikafta Covered by Aetna CVS Health in Ohio Fastest Path: Aetna CVS Health covers Trikafta with prior authorization requiring CFTR genetic testing showing ≥1 F508del mutation, baseline labs, and CF specialist prescription. Submit PA via fax (1-888-267-3277) or phone (1-855-240-0535). If denied, you have 180 days to

Getting Trikafta Renewed with Humana in New Jersey: Timeline, Documentation, and Appeals Guide

Answer Box: Renewing Trikafta with Humana in New Jersey Humana Medicare Advantage requires Trikafta (elexacaftor/tezacaftor/ivacaftor) renewal every 6-12 months with updated clinical documentation. Submit renewal requests 2-4 weeks before expiration with current liver function tests, pulmonary function data (if age ≥6), and prescriber attestation of continued benefit. If